3D-QSAR of histone deacetylase inhibitors as anticancer agents by genetic function approximation

被引:0
|
作者
Wagh, Nilesh K. [1 ]
Deokar, Hemantkumar S. [1 ]
Juvale, Dhanshri C. [1 ]
Kadam, Shivajirao S. [1 ]
Kulkarni, Vithal M. [1 ]
机构
[1] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut Chem, Pune 411038, Maharashtra, India
来源
关键词
3D-QSAR; genetic function approximation; anticancer agents; histone deacetylases; hydroxamic acid analogues; physico-chemical descriptors;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histone deacetylases (HDACs) play a critical role in gene transcription and are implicated in cancer therapy and other diseases. Inhibitors of HDACs induce cell differentiation and suppress cell proliferation in the tumour cells. Athough many such inhibitors have been designed and synthesized, but selective inhibitors for HDAC isoforms are lacking. Various hydroxamic acid analogues have been reported as HDAC inhibitors. Here, we report a three-dimensional quantitative structure-activity relationship (3D-QSAR) Study performed using genetic function approximation (GFA) for this class of molecules. QSAR models were generated using a training set of 39 molecules and the predictive ability of final model was assessed using a test set of 17 molecules. The internal consistency of the final QSAR model was 0.712 and showed good external predictivity of 0.585. The results of the present QSAR study indicated that molecular shape analysis (MSA), thermodynamic and structural descriptors are important for inhibition of HDACs.
引用
收藏
页码:360 / 371
页数:12
相关论文
共 50 条
  • [41] 2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors
    Zhao, Manman
    Wang, Lin
    Zheng, Linfeng
    Zhang, Mengying
    Qiu, Chun
    Zhang, Yuhui
    Du, Dongshu
    Niu, Bing
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [42] 3D-QSAR CoMFA/CoMSIA studies on urokinase plasminogen activator (uPA) inhibitors: a strategic design in novel anticancer agents
    Bhongade, BA
    Gadad, AK
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (10) : 2797 - 2805
  • [43] 3D-QSAR, docking and molecular dynamics for factor Xa inhibitors as anticoagulant agents
    Ghasemi, Jahan B.
    Hooshmand, Shabnam
    MOLECULAR SIMULATION, 2013, 39 (06) : 453 - 471
  • [44] A 3D-QSAR analysis of prolyl endopeptidase inhibitors
    Fehér, M
    Kánai, K
    Hermecz, I
    Lopata, A
    Novák, I
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1999, 18 (05): : 456 - 463
  • [45] Molecular Docking and 3D-QSAR Studies on 7-azaindole Derivatives as Inhibitors of Trk A: A Strategic Design in Novel Anticancer Agents
    Aouidate, Adnane
    Ghaleb, Adib
    Ghamali, Mounir
    Chtita, Samir
    Ousaa, Abdellah
    Choukrad, M'barek
    Sbai, Abdelouahid
    Bouachrine, Mohammed
    Lakhlifi, Tahar
    LETTERS IN DRUG DESIGN & DISCOVERY, 2018, 15 (11) : 1211 - 1223
  • [46] Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents
    Abdel-Atty, Mona M.
    Farag, Nahla A.
    Kassab, Shaymaa E.
    Serya, Rabah A. T.
    Abouzid, Khaled A. M.
    BIOORGANIC CHEMISTRY, 2014, 57 : 65 - 82
  • [47] Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer Agents
    Patel, Preeti
    Singh, Avineesh
    Patel, Vijay K.
    Jain, Deepak K.
    Veerasamy, Ravichandran
    Rajak, Harish
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2016, 19 (09) : 735 - 751
  • [48] Dietary agents as histone deacetylase inhibitors
    Myzak, Melinda C.
    Ho, Emily
    Dashwood, Roderick H.
    MOLECULAR CARCINOGENESIS, 2006, 45 (06) : 443 - 446
  • [49] Histone deacetylase inhibitors as chondroprotective agents
    Culley, K. L.
    Fenwick, S.
    Clark, I. M.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2010, 91 (02) : A36 - A37
  • [50] Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents
    Peng, Xiaopeng
    Chen, Jingxuan
    Li, Ling
    Sun, Zhiqiang
    Liu, Jin
    Ren, Yichang
    Huang, Junli
    Chen, Jianjun
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (12) : 8447 - 8473